These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 14565627)
1. Influence of smoking on predictors of vascular disease. Tsiara S; Elisaf M; Mikhailidis DP Angiology; 2003; 54(5):507-30. PubMed ID: 14565627 [TBL] [Abstract][Full Text] [Related]
2. The relationship of cigarette smoking to peripheral arterial disease. Lu JT; Creager MA Rev Cardiovasc Med; 2004; 5(4):189-93. PubMed ID: 15580157 [TBL] [Abstract][Full Text] [Related]
3. The pathophysiology of cigarette smoking and cardiovascular disease: an update. Ambrose JA; Barua RS J Am Coll Cardiol; 2004 May; 43(10):1731-7. PubMed ID: 15145091 [TBL] [Abstract][Full Text] [Related]
4. Impact of tobacco smoking and smoking cessation on cardiovascular risk and disease. Bullen C Expert Rev Cardiovasc Ther; 2008 Jul; 6(6):883-95. PubMed ID: 18570625 [TBL] [Abstract][Full Text] [Related]
5. Coronary risk factors, endothelial function, and atherosclerosis: a review. Vogel RA Clin Cardiol; 1997 May; 20(5):426-32. PubMed ID: 9134272 [TBL] [Abstract][Full Text] [Related]
6. Smoking and cardiovascular disease: mechanisms of endothelial dysfunction and early atherogenesis. Messner B; Bernhard D Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):509-15. PubMed ID: 24554606 [TBL] [Abstract][Full Text] [Related]
7. Passive smoking, platelet function and atherosclerosis. Kritz H; Sinzinger H Wien Klin Wochenschr; 1996; 108(18):582-8. PubMed ID: 9012142 [TBL] [Abstract][Full Text] [Related]
8. Vascular consequences of smoking and benefits of smoking cessation. Hart BP J Vasc Nurs; 1993 Jun; 11(2):48-51. PubMed ID: 8274378 [TBL] [Abstract][Full Text] [Related]
9. [Cardiovascular diseases secondary to active and passive smoking]. Goich J Rev Med Chil; 1995 May; 122(5):556-62. PubMed ID: 7724898 [TBL] [Abstract][Full Text] [Related]
10. Nutrition, antioxidants, and risk factor profile of nonsmokers, passive smokers and smokers of the Prevention Education Program (PEP) in Nuremberg, Germany. Tröbs M; Renner T; Scherer G; Heller WD; Geiss HC; Wolfram G; Haas GM; Schwandt P Prev Med; 2002 Jun; 34(6):600-7. PubMed ID: 12052020 [TBL] [Abstract][Full Text] [Related]
11. Reactive changes in the blood of smokers and the development of arterial diseases and COPD, a review: evidence of associations between changes and subsequent disease with implications for the evaluation of harmful effects of cigarettes, and for susceptibility to the chronic effects of inhaled pollutants. Anthony HM Rev Environ Health; 1989; 8(1-4):25-86. PubMed ID: 2485924 [TBL] [Abstract][Full Text] [Related]
12. Tobacco-related diseases. Is there a role for antioxidant micronutrient supplementation? Traber MG; van der Vliet A; Reznick AZ; Cross CE Clin Chest Med; 2000 Mar; 21(1):173-87, x. PubMed ID: 10763098 [TBL] [Abstract][Full Text] [Related]
13. [Interaction between the arterial wall and thrombocytes in smokers]. Lassila R; Koskenvuo M; Kaprio J; Laustiola KE Nord Med; 1991; 106(1):8-10. PubMed ID: 1996232 [TBL] [Abstract][Full Text] [Related]
14. Cigarette-smoke-induced atherogenic lipid profiles in plasma and vascular tissue of apolipoprotein E-deficient mice are attenuated by smoking cessation. Lietz M; Berges A; Lebrun S; Meurrens K; Steffen Y; Stolle K; Schueller J; Boue S; Vuillaume G; Vanscheeuwijck P; Moehring M; Schlage W; De Leon H; Hoeng J; Peitsch M Atherosclerosis; 2013 Jul; 229(1):86-93. PubMed ID: 23669247 [TBL] [Abstract][Full Text] [Related]